Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06848530 · ClinicalTrials.gov registry record · NA
Neurophysiology of the Basal Ganglia, Thalamus, and Cerebellum in Patients With Movement Disorders
A NA study of Movement Disorders, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06848530 is a NA study of Movement Disorders that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 100 participants, below the 1,064-participant average among 26 other Movement Disorders trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06848530, a NA study of Movement Disorders, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The research study is being conducted to better understand parts of the human brain called the cortex, basal ganglia, thalamus, and cerebellum in patients with movement disorders (such as Parkinson's disease, essential tremor, dystonia, or ataxia). These brain structures are involved in movement disorders. This study attempts to better understand the brain electrical activity associated with these disorders, both in patients with and without deep brain stimulation (DBS). Recordings are made from the scalp with a noninvasive electrode and/or through the DBS stimulator if the participant has a stimulator model that is able to sense brain activity. These recordings are analyzed along with measures of movement disorder symptoms to identify brain signal signatures of symptoms.
Conditions Studied
Interventions
- OTHER Prescribed Medications
- OTHER Deep brain stimulation adjustment
Study Locations (1)
Pennsylvania
- Pennsylvania Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-12-10 |
| Est. Completion | 2030-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06848530
The ClinicalTrials.gov registry entry for NCT06848530 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,064-participant average among 26 other Movement Disorders trials with a reported enrollment target (91% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Movement Disorders appearing as the primary indexed condition, and to 2 interventions - of which Prescribed Medications is the first listed.
NCT06848530 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06848530 about?
NCT06848530 is a clinical study titled "Neurophysiology of the Basal Ganglia, Thalamus, and Cerebellum in Patients With Movement Disorders". The research study is being conducted to better understand parts of the human brain called the cortex, basal ganglia, thalamus, and cerebellum in patients with movement disorders (such as Parkinson's disease, essential tremor, dystonia, or ataxia). These brain structures are involved in movement dis...
What is the current status of trial NCT06848530?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-12-10. Estimated completion is 2030-04.
What conditions does trial NCT06848530 study?
This clinical trial studies the following conditions: Movement Disorders.
What interventions are being tested in trial NCT06848530?
The interventions under investigation include: Prescribed Medications (OTHER), Deep brain stimulation adjustment (OTHER).
Who is sponsoring clinical trial NCT06848530?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06848530 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Movement Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Analysis of Human Movement With Assistive Devices
RECRUITING · NA
-
Non-invasive BCI-controlled Assistive Devices
RECRUITING · NA
-
Neurophysiological, Behavioral, and Cognitive Networks in Movement Disorders
RECRUITING · NA
-
Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease
RECRUITING · NA
-
Leg Stretching Using an Exoskeleton on Demand for People With Spasticity
RECRUITING · NA
-
Towards Restoring Complex Movement After Paralysis: Algorithm Development With Healthy Participants
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.